Are stroke biomarkers seeing brain vessels in patients with ischemic stroke?: A C-reactive protein and homocysteine study

Stroke

Volumn 42, Issue 5, 2011, Pages 1464-1468

  Kim, Suk Jae ^a   Choe, Yeon Hyeon ^a   Bang, Oh Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

atherosclerosis; biomarker; C reactive protein; cardiac; homocysteine

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BIOLOGICAL MARKERS; BRAIN; C-REACTIVE PROTEIN; CEREBRAL ARTERIES; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STROKE;

EID: 79955366471     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.607432     Document Type: Article

References (11)

1. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: The PRECORIS study. Circulation. 2010;121:1623-1629.
2. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, Hofman A, Witteman JC. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 2002;22:838-842. (Pubitemid 34517798)
3. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an inde-pendent risk marker for subclinical carotid atherosclerosis. Stroke. 2004; 35:1619-1624. (Pubitemid 38823636)
4. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
5. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis. 2004;176:1-19. (Pubitemid 39078639)
6. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circu-lating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397. (Pubitemid 38419992)
7. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843. (Pubitemid 30165206)
8. Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL. High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study. Neurology. 2009;73:1300-1307.
9. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: The Rotterdam study. Circulation. 2006;114:1591-1598. (Pubitemid 44547429)
10. Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, Shipley M, Abrams KR, Moreno S, McAllister KSL, Palmer S, Kaski JC, Timmis AD, Hingorani AD. Evaluating the quality of research into a single prognostic biomarker: A systematic review and meta-analysis of 83 studies of c-reactive protein in stable coronary artery disease. PLoS Med. 2010;7:e1000286.
11. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW, REACH Registry Investi-gators. International prevalence, recognition, and treatment of cardiovas-cular risk factors in outpatients with atherothrombosis. JAMA. 2006;295: 180-189 (Pubitemid 43076437)